- Home
- MTEM vs BMRA Comparison
MTEM vs BMRA Comparison
Compare MTEM & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- BMRA
- Stock Information
- Founded
- MTEM 2001
- BMRA 1971
- Country
- MTEM United States
- BMRA United States
- Employees
- MTEM N/A
- BMRA N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MTEM Health Care
- BMRA Health Care
- Exchange
- MTEM Nasdaq
- BMRA Nasdaq
- Market Cap
- MTEM 9.7M
- BMRA 7.4M
- IPO Year
- MTEM N/A
- BMRA N/A
- Fundamental
- Price
- MTEM $0.71
- BMRA $0.32
- Analyst Decision
- MTEM
- BMRA
- Analyst Count
- MTEM 0
- BMRA 0
- Target Price
- MTEM N/A
- BMRA N/A
- AVG Volume (30 Days)
- MTEM 13.4M
- BMRA 68.2K
- Earning Date
- MTEM 11-11-2024
- BMRA 10-15-2024
- Dividend Yield
- MTEM N/A
- BMRA N/A
- EPS Growth
- MTEM N/A
- BMRA N/A
- EPS
- MTEM N/A
- BMRA N/A
- Revenue
- MTEM $25,470,000.00
- BMRA $5,509,000.00
- Revenue This Year
- MTEM N/A
- BMRA N/A
- Revenue Next Year
- MTEM N/A
- BMRA N/A
- P/E Ratio
- MTEM N/A
- BMRA N/A
- Revenue Growth
- MTEM N/A
- BMRA 1.74
- 52 Week Low
- MTEM $0.30
- BMRA $0.24
- 52 Week High
- MTEM $6.48
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- MTEM 38.68
- BMRA 47.45
- Support Level
- MTEM $0.31
- BMRA $0.28
- Resistance Level
- MTEM $1.34
- BMRA $0.35
- Average True Range (ATR)
- MTEM 0.14
- BMRA 0.03
- MACD
- MTEM -0.05
- BMRA 0.00
- Stochastic Oscillator
- MTEM 34.48
- BMRA 38.50
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.